LakeShore Biopharma Co., Ltd. (LSBCF) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | 614.96M CNY | +7.2% |
| 2024 | 573.42M CNY | -16.6% |
| 2023 | 687.20M CNY | +36.6% |
| 2022 | 502.95M CNY | +95.7% |
| 2021 | 257.02M CNY | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | 614.96M CNY | +7.2% |
| 2024 | 573.42M CNY | -16.6% |
| 2023 | 687.20M CNY | +36.6% |
| 2022 | 502.95M CNY | +95.7% |
| 2021 | 257.02M CNY | — |